HomeNIRV • CNSX
add
Nirvana Life Sciences Inc
Previous close
$0.075
Year range
$0.030 - $0.50
Market cap
361.75K CAD
Avg Volume
1.91K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 79.99K | 43.43% |
Net income | -90.84K | -48.65% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.86K | 199.84% |
Total assets | 20.57K | -89.49% |
Total liabilities | 634.60K | -55.84% |
Total equity | -614.04K | — |
Shares outstanding | 22.93M | — |
Price to book | -2.50 | — |
Return on assets | -1,025.21% | — |
Return on capital | 44.44% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -90.84K | -48.65% |
Cash from operations | -62.53K | -118.09% |
Cash from investing | — | — |
Cash from financing | 61.61K | 63.79% |
Net change in cash | 112.00 | 103.23% |
Free cash flow | -37.50K | -80.28% |
About
Founded
2011
Headquarters
Website
Employees
2
